Results 101 to 110 of about 6,810 (154)
Some of the next articles are maybe not open access.
Ocular Aspects of Myasthenia Gravis
Seminars in Neurology, 2000Ocular myasthenia gravis is a not uncommon autoimmune disorder causing diplopia, ptosis, and weakness of lid closure. The predilection of myasthenia for the ocular muscles may be related to differences between limb and extraocular muscles in either physiological function or antigenicity. Clinically, ocular myasthenia can mimic any form of pupil-sparing
J J Barton
exaly +3 more sources
S.S. Korsakov Journal of Neurology and Psychiatry, 2023
The article describes an urgent medical and social problem — the diagnosis and treatment of the ocular myasthenia gravis. Despite recent advances in the study of synaptic pathology, the diagnosis of the ocular form of myasthenia gravis remains a challenging problem. This is due to the poor information content of laboratory and electromyographic methods
A.G. Sanadze +3 more
openaire +3 more sources
The article describes an urgent medical and social problem — the diagnosis and treatment of the ocular myasthenia gravis. Despite recent advances in the study of synaptic pathology, the diagnosis of the ocular form of myasthenia gravis remains a challenging problem. This is due to the poor information content of laboratory and electromyographic methods
A.G. Sanadze +3 more
openaire +3 more sources
Prognosis of ocular myasthenia
Annals of Neurology, 1983AbstractA retrospective study of 108 patients with myasthenia gravis who had solely ocular symptoms and signs at onset was carried out to identify factors influencing prognosis. Increasing duration of pure ocular myasthenia was associated with a decreasing risk of late generalized symptoms; only 9 (15%) of the observed generalizations occurred after ...
C T, Bever +4 more
openaire +2 more sources
Neurology, 1981
Three patients with ocular myasthenia in childhood experienced complete and prolonged remissions lasting 4 to 14 years and then suffered recurrences of ocular myasthenia. One had another spontaneous remission and then relapsed again. All were subsequently in remission on oral steroid medication.
R D, Rollinson, G M, Fenichel
openaire +2 more sources
Three patients with ocular myasthenia in childhood experienced complete and prolonged remissions lasting 4 to 14 years and then suffered recurrences of ocular myasthenia. One had another spontaneous remission and then relapsed again. All were subsequently in remission on oral steroid medication.
R D, Rollinson, G M, Fenichel
openaire +2 more sources
Current Treatment Options in Neurology, 2005
Myasthenia gravis (MG) is an autoimmune disorder characterized clinically by proximal weakness and bulbar symptoms and pathologically by damage to the post-synaptic membrane at the neuromuscular junction. Ocular myasthenia gravis (ocular MG) is a form of myasthenia gravis whereby the patients' weakness is limited to the muscles of the eyes and eyelids (
Neil C, Porter, Brian C, Salter
openaire +2 more sources
Myasthenia gravis (MG) is an autoimmune disorder characterized clinically by proximal weakness and bulbar symptoms and pathologically by damage to the post-synaptic membrane at the neuromuscular junction. Ocular myasthenia gravis (ocular MG) is a form of myasthenia gravis whereby the patients' weakness is limited to the muscles of the eyes and eyelids (
Neil C, Porter, Brian C, Salter
openaire +2 more sources
Current Treatment Options in Neurology, 2001
Treatment decisions for ocular myasthenia gravis (OMG) should be based on symptomatology. Local, nonpharmacologic treatment of ptosis or diplopia is successful in relatively few patients, and the majority of patients require drug therapy for satisfactory resolution of their symptoms.
Victoria S., Pelak, Steven L., Galetta
openaire +2 more sources
Treatment decisions for ocular myasthenia gravis (OMG) should be based on symptomatology. Local, nonpharmacologic treatment of ptosis or diplopia is successful in relatively few patients, and the majority of patients require drug therapy for satisfactory resolution of their symptoms.
Victoria S., Pelak, Steven L., Galetta
openaire +2 more sources
Ophthalmology Clinics of North America, 2004
Myasthenia gravis may be limited solely to the eyes (ocular myasthenia) or may have systemic manifestations (generalized myasthenia). Most patients display blepharoptosis or ophthalmoparesis, resulting in diplopia, but the ocular motility disorder may take many forms. The diagnosis is often elucidated by variable muscle weakness with fatigability noted
Rachael D, Elrod, David A, Weinberg
openaire +2 more sources
Myasthenia gravis may be limited solely to the eyes (ocular myasthenia) or may have systemic manifestations (generalized myasthenia). Most patients display blepharoptosis or ophthalmoparesis, resulting in diplopia, but the ocular motility disorder may take many forms. The diagnosis is often elucidated by variable muscle weakness with fatigability noted
Rachael D, Elrod, David A, Weinberg
openaire +2 more sources
Ocular myasthenia and nitrofurantoin
American Journal of Ophthalmology, 2000To report a case of ocular myasthenia associated with administration of nitrofurantoin.Case report and review of the literature.While taking nitrofurantoin after urinary tract surgery, a 10-year-old female developed diplopia and ptosis. Sleep test confirmed ocular myasthenia.
B N, Wasserman +3 more
openaire +2 more sources
Current Opinion in Ophthalmology, 2012
To review ocular myasthenia gravis (OMG), a localized form of myasthenia gravis clinically involving only the extraocular, levator palpebrae superioris, and orbicularis oculi muscles.Ocular manifestations can masquerade as a variety of ocular motility disorders, including central nervous system disorders and peripheral cranial nerve palsies.
Michael S, Vaphiades +2 more
openaire +2 more sources
To review ocular myasthenia gravis (OMG), a localized form of myasthenia gravis clinically involving only the extraocular, levator palpebrae superioris, and orbicularis oculi muscles.Ocular manifestations can masquerade as a variety of ocular motility disorders, including central nervous system disorders and peripheral cranial nerve palsies.
Michael S, Vaphiades +2 more
openaire +2 more sources
The Neurologist, 2006
Although myasthenia gravis (MG) is often considered the best-understood autoimmune disorder and effective treatments have controlled life-threatening complications, the pathogenesis of ocular myasthenia (OM) remains enigmatic, and its clinical consequences offer therapeutic challenges.About half of patients with MG present with visual complaints of ...
Linda L, Kusner +2 more
openaire +2 more sources
Although myasthenia gravis (MG) is often considered the best-understood autoimmune disorder and effective treatments have controlled life-threatening complications, the pathogenesis of ocular myasthenia (OM) remains enigmatic, and its clinical consequences offer therapeutic challenges.About half of patients with MG present with visual complaints of ...
Linda L, Kusner +2 more
openaire +2 more sources